Researchers evaluated the use of ultrawide field swept-source OCT-A to evaluate retinal vasculature in patients with sickle cell retinopathy.

The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at MUSC have joined forces to create and test an ...

MONDAY, March 17, 2025 (HealthDay News) -- For 21 years, Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic treatment, he is the first ...

Sebastien Beauzile, 21, has been cured of sickle cell anemia, according to his doctors at Cohen’s Children’s Medical Center. Beauzile received a new gene therapy called Lyfgeni, created by the ...

He had come to Florida to surprise his sister for her birthday. But instead, he had become so weak from sickle cell anemia that he had to be carried into a local hospital, then sent to another ...

The former is identified by an alteration in a single gene and encompasses diseases like hemophilia, thalassemia, cystic fibrosis, Duchenne muscular dystrophy, and sickle-cell anemia. The alteration ...

The commemorative stamp honours Madhya Pradesh’s initiative to combat the high prevalence of sickle cell anemia in tribal regions and highlights the commitment to eradicate this hereditary ...

Sickle cell anemia may qualify as a disability for people experiencing severe symptoms, allowing access to benefits. However, eligibility depends on how the condition affects daily life.

September is National Sickle Cell Anemia Awareness Month. Sickle cell anemia is a disease that is inherited genetically through a trait passed to a child by both parents, affecting the blood cells.

Patients with sickle cell anemia (SCA) and persistent albuminuria (PA) exhibited significantly higher levels of urinary angiotensinogen (AGT). “What we’re most excited about is that urinary ...

September Is Sickle Cell Awareness Month. While many people are familiar with sickle cell anemia, sickle cell traits have also plagued our community. Sickle cell trait (SCT) is an inherited blood ...

Pauling dubbed sickle cell anemia a “molecular disease.” That framing effectively launched the biomedical era of newly powerful laboratory research. Mark T. Gladwin, a longtime sickle cell ...